US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

757.39

+25.603.50%

Post-market: 748.37-9.0200-1.19%19:59 EDT

Volume:4.65M

Turnover:3.49B

Market Cap:717.81B

PE:64.68

High:758.87

Open:740.00

Low:738.00

Close:731.79

Loading ...

Overview Company News Filings

Eli Lilly and Co - Common Adverse Events for Orforglipron Were Gastrointestinal-Related

THOMSON REUTERS

Eli Lilly and Co - Orforglipron Meets Primary Endpoint of a1c Reduction in Phase 3 Trial

THOMSON REUTERS

Lilly's Oral Glp-1, Orforglipron, Demonstrated Statistically Significant Efficacy Results and a Safety Profile Consistent With Injectable Glp-1 Medicines in Successful Phase 3 Trial

THOMSON REUTERS

Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

BUZZ-BMO downgrades Novo Nordisk on faltering lead over Lilly in obesity

Eli Lilly & Co. Stock Underperforms Wednesday When Compared To Competitors

Novo Nordisk A/S (NVO): A Bull Case Theory

Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?

Eli Lilly (LLY) Gains As Market Dips: What You Should Know

European pharma companies issue demands to stay in EU ahead of expected US tariffs

Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth?

Pfizer Halts Obesity Pill Development Amid Safety Concerns

VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke

Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In

Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab and Tirzepatide Combination in Preclinical Model

THOMSON REUTERS

Skye Bioscience Inc - Nimacimab Phase 2a Top-Line Data Expected Late Q3/Early Q4 2025

THOMSON REUTERS

Skye Bioscience Inc - Nimacimab Shows Additive Weight Loss Effect With Tirzepatide in Dio Model

THOMSON REUTERS

Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LLY/news?page=17"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LLY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LLY\",,,,,undefined,":{"symbol":"LLY","market":"US","secType":"STK","nameCN":"Eli Lilly","latestPrice":757.39,"timestamp":1747425600000,"preClose":731.79,"halted":0,"volume":4645121,"hourTrading":{"tag":"盘后","latestPrice":748.37,"preClose":757.39,"latestTime":"19:59 EDT","volume":180319,"amount":136529894.259501,"timestamp":1747439989604},"delay":0,"floatShares":946000000,"shares":947735651,"eps":11.71,"marketStatus":"Market Closed","change":25.6,"latestTime":"05-16 16:00:00 EDT","open":740,"high":758.87,"low":738,"amount":3493085005.3021,"amplitude":0.028519,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":11.71,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":102488400000,"exchange":"NYSE","adjPreClose":731.79,"dividendRate":0.00713,"preHourTrading":{"tag":"盘前","latestPrice":735.87,"preClose":731.79,"latestTime":"09:29 EDT","volume":34209,"amount":25360835.3082,"timestamp":1747402199172},"postHourTrading":{"tag":"盘后","latestPrice":748.37,"preClose":757.39,"latestTime":"19:59 EDT","volume":180319,"amount":136529894.259501,"timestamp":1747439989604},"volumeRatio":0.7604006859435941,"optionData":{"bulkOrders":[{"symbol":"LLY","call":true,"expireDate":1750392000000,"strike":"850.0","timestamp":1747420026958,"price":7.2,"volume":4008,"amount":2885760,"type":"+"},{"symbol":"LLY","call":true,"expireDate":1750392000000,"strike":"960.0","timestamp":1747420026958,"price":1.2,"volume":4008,"amount":480960,"type":"-"}]},"impliedVol":0.3705,"impliedVolPercentile":0.572},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LLY\",,,,,undefined,":{"symbol":"LLY","floatShares":946000000,"roa":"16.45%","roe":"77.28%","lyrEps":11.758762,"volumeRatio":0.7604006859435941,"shares":947735651,"dividePrice":5.4,"high":758.87,"amplitude":0.028519,"preClose":731.79,"low":738,"week52Low":677.0912,"pbRate":"45.53","psRate":"14.65","week52High":972.53,"institutionHeld":0.8029,"latestPrice":757.39,"eps":11.71,"divideRate":0.00713,"volume":4645121,"delay":0,"ttmEps":11.71,"open":740,"prevYearClose":772,"prevWeekClose":734.57,"prevMonthClose":898.95,"prevQuarterClose":825.91,"fiveDayClose":734.57,"twentyDayClose":839.96,"sixtyDayClose":873.12},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LLY\",pageSize:20,pageCount:17,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528792768","title":"Eli Lilly and Co - Common Adverse Events for Orforglipron Were Gastrointestinal-Related","url":"https://stock-news.laohu8.com/highlight/detail?id=2528792768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528792768?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:45","pubTimestamp":1744886703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA73V7TJ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","LU2357305700.SGD","LU1023059063.AUD","LU2491050154.USD","LU1868836757.USD","LU2471134796.USD","LU0320765059.SGD","SG9999001176.SGD","LU0106261372.USD","LU2237443895.HKD","LU0114720955.EUR","SG9999013999.USD","LU1069344957.HKD","LU0109391861.USD","SGXZ51526630.SGD","LU0097036916.USD","LLY","LU1720051017.SGD","LU0203201768.USD","SGXZ81514606.USD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1093756168.USD","LU2491049909.HKD","LU1232071149.USD","SG9999015945.SGD","LU1267930730.SGD","LU1623119135.USD","LU2552382215.SGD","LU2471134523.USD","IE0004445239.USD","LU0456855351.SGD","LU1061106388.HKD","IE0009355771.USD","LU1868836914.USD","LU2264538146.SGD","LU0820561909.HKD","LU2237443382.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU1814569148.SGD","LU0708995401.HKD","LU1989771016.USD","LU2063271972.USD","LU0882574055.USD","LU2211815571.USD","LU0058720904.USD","SG9999001176.USD","LU1280957306.USD"],"gpt_icon":0},{"id":"2528792766","title":"Eli Lilly and Co - Orforglipron Meets Primary Endpoint of a1c Reduction in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528792766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528792766?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:45","pubTimestamp":1744886703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA73V7TJ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4581","LU0820561909.HKD","LU2357305700.SGD","LU1989771016.USD","LU0640476718.USD","LLY","LU2471134523.USD","LU2237443382.USD","LU0106261372.USD","LU2491050154.USD","LU0097036916.USD","LU1623119135.USD","IE0009355771.USD","LU0109391861.USD","IE00BJT1NW94.SGD","IE0004445239.USD","LU2237443895.HKD","LU0320765059.SGD","SG9999001176.USD","SG9999013999.USD","IE00BFTCPJ56.SGD","LU0708995401.HKD","SGXZ81514606.USD","LU1023059063.AUD","LU2491049909.HKD","LU1814569148.SGD","LU0882574055.USD","LU1093756168.USD","LU1232071149.USD","LU2552382215.SGD","SGXZ51526630.SGD","LU0203201768.USD","LU1267930730.SGD","LU2471134796.USD","LU0114720955.EUR","LU1069344957.HKD","SG9999001176.SGD","LU2063271972.USD","IE00BJJMRZ35.SGD","LU1280957306.USD","LU1061106388.HKD","LU1868836914.USD","SG9999015945.SGD","LU2211815571.USD","LU0058720904.USD","LU2264538146.SGD","LU1720051017.SGD","LU0456855351.SGD","LU1868836757.USD"],"gpt_icon":0},{"id":"2528763792","title":"Lilly's Oral Glp-1, Orforglipron, Demonstrated Statistically Significant Efficacy Results and a Safety Profile Consistent With Injectable Glp-1 Medicines in Successful Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528763792","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528763792?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:45","pubTimestamp":1744886703,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA73V7TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1814569148.SGD","LU1989771016.USD","BK4581","LU1069344957.HKD","LU2471134796.USD","SG9999001176.USD","LU1280957306.USD","LU2211815571.USD","LU0109391861.USD","IE0004445239.USD","LU1720051017.SGD","LU2552382215.SGD","LU2491050154.USD","LU0820561909.HKD","IE0009355771.USD","SG9999001176.SGD","LU2471134523.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","LU0640476718.USD","LU1061106388.HKD","LU0097036916.USD","SG9999013999.USD","LU1868836914.USD","LU2089984988.USD","LU0106261372.USD","LU2237443895.HKD","LU2237443382.USD","IE00BFTCPJ56.SGD","LU1267930730.SGD","LU2491049909.HKD","LU1868836757.USD","SG9999015945.SGD","SGXZ81514606.USD","LU0708995401.HKD","LU1623119135.USD","LU2264538146.SGD","LU0456855351.SGD","LU2063271972.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0114720955.EUR","LU1093756168.USD","LLY","LU0320765059.SGD","LU2357305700.SGD","LU1023059063.AUD","SGXZ51526630.SGD","LU0203201768.USD"],"gpt_icon":0},{"id":"2528373790","title":"Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2528373790","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528373790?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:45","pubTimestamp":1744886700,"startTime":"0","endTime":"0","summary":"Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses. The overall safety and tolerability profile oforforglipron in ACHIEVE-1 was consistent with injectable GLP-1 therapies. In the first Phase 3 trial of the ACHIEVE program, orforglipron met the primary endpoint of superior A1C reduction compared to placebo at 40 weeks, lowering A1C by an average of 1.3% to 1.6% from a baseline of 8.0%, using the efficacy estimand.2 In a key secondary endpoint, more than 65% of participants taking the highest dose of orforglipron achieved an A1C less than or equal to 6.5%, which is below the American Diabetes Association's  defined threshold for diabetes.3 In an additional key secondary endpoint, participants taking orforglipron lost an average of 16.0 lbs  at the highest dose. Given that participants had not yet reached a weight plateau at the time the study ended, it appears that full weight reduction was not ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lillys-oral-glp-1-orforglipron-104500810.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lillys-oral-glp-1-orforglipron-104500810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4144","LU0238689110.USD","LU1983299246.USD","BK4599","LU0289739699.SGD","LU2264538146.SGD","LU0640476718.USD","LU0096364046.USD","SGXZ99366536.SGD","LU0820561818.USD","BK4590","LU0061475181.USD","IE00BK4W5L77.USD","LU1061106388.HKD","BK4585","LU2023250504.SGD","SGXZ31699556.SGD","LU2491050071.SGD","LU0097036916.USD","SG9999015945.SGD","SGXZ51526630.SGD","LU1280957306.USD","LU2237443465.HKD","LU0354030511.USD","LU0122379950.USD","LU1868836591.USD","LU2237443978.SGD","LLY","LU2237438978.USD","LU2324357040.USD","LU2552382058.USD","SG9999015978.USD","LU2750360641.GBP","LU0882574055.USD","LU0882574139.USD","IE00B1BXHZ80.USD","SGXZ81514606.USD","IE00BJLML261.HKD","LU0417517546.SGD","LU2112291526.USD","LU0198837287.USD","LU2361044949.HKD","LU1551013425.SGD","LU2602419157.SGD","LU1712237335.SGD","SG9999014880.SGD","GLP","LU0820561909.HKD","LU1232071149.USD","LU0094547139.USD"],"gpt_icon":1},{"id":"2528794730","title":"BUZZ-BMO downgrades Novo Nordisk on faltering lead over Lilly in obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2528794730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528794730?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:31","pubTimestamp":1744885888,"startTime":"0","endTime":"0","summary":"BUZZ-BMO downgrades Novo Nordisk on faltering lead over Lilly in obesity** Brokerage BMO Capital Markets believes Danish drugmaker Novo Nordisk's NOVOb.CO obesity rival Eli Lilly LLY.N has made sizable advancements in its commercial and clinical portfolio, causing it to overtake Novo's early lead** BMO cuts PT for Novo Nordisk NOVOb.CO to $64 from $105, downgrades stock rating to \"market perform\" from \"outperform\"** BMO says Novo's \"first mover advantage\" with semaglutide, the active ingredient in its weight loss and diabetes drugs, has waned with Lilly's tirezepatide taking share rapidly** BMO sees this trend accelerating with Lilly's experimental oral weight loss drug orforglipron and so-called \"triple-G\" weight-loss drug candidate retatrutide** Brokerage also believes Novo will have a \"softer Q1\"** Nineteen of 26 brokerages rate the stock \"buy\" or higher, 7 \"hold\" and 1 \"sell\" or lower; their median PT is 700 DKK  - data compiled by LSEG ** Up to last close, stock down 32.5% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nL4N3QV0TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY"],"gpt_icon":1},{"id":"2528270489","title":"Eli Lilly & Co. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2528270489","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528270489?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:31","pubTimestamp":1744835460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Eli Lilly & Co.  shed 2.94% to $734.90 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 2.24% to 5,275.70 and Dow Jones Industrial Average  falling 1.73% to 39,669.39.The stock's fall snapped a three-day winning streak.Eli Lilly & Co. closed 24.43% short of its 52-week high of $972.53, which the company reached on August 22nd.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 0.19% to $153.91, Pfizer Inc.  fell 1.78% to $22.04, and AbbVie Inc.  fell 2.90% to $171.68.Trading volume  remained 407,550 below its 50-day average volume of 3.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 16, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY"],"gpt_icon":1},{"id":"2528027186","title":"Novo Nordisk A/S (NVO): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2528027186","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528027186?lang=en_us&edition=fundamental","pubTime":"2025-04-17 02:37","pubTimestamp":1744828655,"startTime":"0","endTime":"0","summary":"We came across abullish thesison Novo Nordisk A/S  on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S 's share was trading at $64.49 as of April 15th. NVO’s trailing and forward P/E were 18.76 and 15.41 respectively according to Yahoo Finance.Novo Nordisk’s dominance in the diabetes care market is also under threat from competitors like Lilly, but the company remains focused on expanding its footprint, particularly in emerging markets. Novo’s market share in diabetes care grew from 29.9% to 31.6% in 2023, with the company targeting over 33% market share by 2025. This growth is fueled by the rising prevalence of diabetes and obesity, particularly in countries like China and Africa, where Novo’s sales have surged. In addition to its strong presence in diabetes care, Novo is also innovating to maintain its competitive edge, exemplified by its $11 billion acquisition of three Catalent manufactur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-nvo-bull-case-183735432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2237443549.SGD","LU1814569148.SGD","LU1988902786.USD","SG9999001176.SGD","LU1548497426.USD","BK4532","BK4588","IE00BZ1G4Q59.USD","LU1280957306.USD","IE00BJLML261.HKD","LU0882574139.USD","IE0009355771.USD","LU0471298777.SGD","LU1023059063.AUD","LU1868836914.USD","IE00BJJMRZ35.SGD","LU0238689110.USD","NVO","LU2357305700.SGD","LU2089984988.USD","LLY","SG9999014914.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2552382215.SGD","LU0882574055.USD","LU0097036916.USD","LU1868837300.USD","LU0672654240.SGD","IE0004445239.USD","LU2023250504.SGD","IE0002141913.USD","IE00BK4W5M84.HKD","LU0256863902.USD","LU0094547139.USD","LU0354030438.USD","LU1267930730.SGD","LU0109391861.USD","BK4533","SG9999015978.USD","SG9999015945.SGD","SG9999018865.SGD","SGXZ51526630.SGD","SG9999015952.SGD","SG9999013999.USD","BK4585","LU1720051017.SGD","LU2237443382.USD","LU2471134796.USD","LU1035775433.USD"],"gpt_icon":1},{"id":"2527243766","title":"Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527243766","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527243766?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:05","pubTimestamp":1744801500,"startTime":"0","endTime":"0","summary":"Eli Lilly and Company’s LLY shares have lost 8.2% in the past month. A lot of this price decline is due to the global uncertainty caused by the tariff war. With the Trump administration imposing sweeping tariffs, fears of a global recession resulted in a stock market rout worldwide. Though pharmaceuticals have been exempted from tariffs in the first round of reciprocal tariffs, they could well be Trump’s target in the next round, considering the President’s goal to shift pharmaceutical productionback to the United States, mostly from European and Asian countries.Stocks of both Lilly and rival Novo Nordisk NVO declined recently as Medicare excluded their expensive weight-loss medicines from its Part D prescription drug coverage.Let’s understand the company’s strengths and weaknesses to better analyze how to play the stock amid the broader market uncertainty.Despite being on the market for less than three years, Mounjaro and Zepbound became key top-line drivers for Lilly in 2024, with de","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-stock-down-8-110500046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","LU1814569148.SGD","LU1989771016.USD","LU0203202063.USD","LU2471134796.USD","LU0109394709.USD","LU2471134879.HKD","IE00B1BXHZ80.USD","LU1720051017.SGD","LU1988902786.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2552382215.SGD","LU0154236417.USD","LU2491050154.USD","VKTX","BK4532","LU1291159041.SGD","LU1057294990.SGD","LU0198837287.USD","LU2089984988.USD","LU2461242641.AUD","NVO","LU0106261372.USD","BK4566","LU0289739699.SGD","LU2237443895.HKD","SG9999018865.SGD","LU0882574139.USD","LU2237443382.USD","LU1267930730.SGD","LU1868836757.USD","AMGN","SG9999015945.SGD","LU2112291526.USD","LU1804176565.USD","LU1623119135.USD","LU1917777945.USD","IE00BJJMRZ35.SGD","SGXZ99366536.SGD","LU1551013425.SGD","GB00BDT5M118.USD","LLY","SGXZ57979304.SGD","LU1868837136.USD","LU0943347566.SGD","LU1571399168.USD","LU0096364046.USD","SGXZ51526630.SGD","LU0385154629.USD"],"gpt_icon":1},{"id":"2527976403","title":"Eli Lilly (LLY) Gains As Market Dips: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2527976403","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527976403?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:45","pubTimestamp":1744753516,"startTime":"0","endTime":"0","summary":"Eli Lilly  ended the recent trading session at $757.18, demonstrating a +0.38% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.17%. At the same time, the Dow lost 0.39%, and the tech-heavy Nasdaq lost 0.05%.Heading into today, shares of the drugmaker had lost 8.54% over the past month, lagging the Medical sector's loss of 6.9% and the S&P 500's loss of 3.94% in that time.The investment community will be closely monitoring the performance of Eli Lilly in its forthcoming earnings report. The company is scheduled to release its earnings on May 1, 2025. It is anticipated that the company will report an EPS of $4.62, marking a 79.07% rise compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $12.7 billion, up 44.79% from the year-ago period.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-lly-gains-market-214516146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999014906.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU2750360641.GBP","LLY","LU2237443465.HKD","SGXZ51526630.SGD","LU2023250504.SGD","SG9999015945.SGD","BK4516","BK4533","LU1093756325.SGD","LU1548497426.USD","LU2552382215.SGD","SG9999015986.USD","SG9999014914.USD","IE00B4R5TH58.HKD","LU0106261372.USD","LU1974910355.USD","LU2471134952.CNY","LU2361044865.SGD","IE00BK4W5M84.HKD","IE00B1BXHZ80.USD","LU0058720904.USD","LU1093756168.USD","LU1057294990.SGD","LU2211815571.USD","LU1267930730.SGD","LU1868836757.USD","IE00B2B36J28.USD","SG9999018857.SGD","LU2361045086.USD","LU0079474960.USD","BK4534","GB00BDT5M118.USD","SG9999018865.SGD","LU2357305700.SGD","IE00BJLML261.HKD","LU1720051017.SGD","LU1868837136.USD","IE0002141913.USD","LU0061475181.USD","IE00BK4W5L77.USD","LU0417517546.SGD","LU1291159041.SGD","LU0471298694.HKD","LU0689472784.USD","LU2063271972.USD","LU2471134796.USD","LU1035775433.USD"],"gpt_icon":1},{"id":"2527142930","title":"European pharma companies issue demands to stay in EU ahead of expected US tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527142930","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527142930?lang=en_us&edition=fundamental","pubTime":"2025-04-16 02:27","pubTimestamp":1744741620,"startTime":"0","endTime":"0","summary":"European pharma companies issue demands to stay in EU ahead of expected US tariffs PARIS, April 15 (Reuters) - Nearly three dozen global pharmaceutical companies, in a letter to the head of the Europe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nL1N3QT0TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0385154629.USD","LU0203202063.USD","SGXZ31699556.SGD","AZN.UK","SG9999018857.SGD","PFE","BK4007","LU1551013425.SGD","SG9999002232.USD","LU1868836591.USD","IE0004445239.USD","LU0047473722.SGD","LU1880407215.USD","LU0466842654.USD","LU2237443549.SGD","LU1003077747.HKD","LU1051770623.HKD","LU1712237335.SGD","IE00B3T34201.USD","LU0575583348.USD","LLY","LU0784385840.USD","LU1989771016.USD","LU0029864427.USD","IE00BFTCPJ56.SGD","LU2023250504.SGD","LU2237443465.HKD","LU2491049909.HKD","LU0456855351.SGD","LU2471134952.CNY","LU2264538146.SGD","LU0109391861.USD","LU1035775433.USD","LU0496365809.HKD","LU1267930573.SGD","LU0061475181.USD","LU1280957306.USD","LU1323610961.USD","SG9999011175.SGD","LU2461242641.AUD","LU0306807586.USD","LU0889565080.SGD","LU0972486137.USD","LU1868836914.USD","03165","LU2602419157.SGD","BK4599","LU2089284900.SGD","LU0114720955.EUR","LU0661504455.SGD"],"gpt_icon":1},{"id":"2527429882","title":"Is Eli Lilly and Company (LLY) the Best Pharma Stock to Buy for Long Term Growth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527429882","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527429882?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:36","pubTimestamp":1744738597,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where Eli Lilly and Company  stands against other best pharma stocks to buy for long term growth.With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before. About 30% of Big Pharma acquisitions involving at least $50 million upfront in 2024 involved Chinese corporations, according to DealForma statistics, as reported by CNBC. This was an increase from 20% the previous year and nearly 0% just five years before.Speaking about the tariffs, she stated that since some businesses assemble their products in the US after producing them overseas, their implementation raises several unanswered questions for the pharmaceutical industry. These businesses, therefore, have relatively low manufacturing costs, which is an important factor to take into account when","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-company-lly-best-173637155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B4R5TH58.HKD","LU1280957306.USD","BK4533","LU2491050154.USD","IE00BK4W5L77.USD","LU2237443465.HKD","LU1868836591.USD","LU0471298777.SGD","LU0097036916.USD","LU0256863902.USD","SGXZ57979304.SGD","SG9999001176.USD","LU1127390331.HKD","LU1069344957.HKD","LU0006306889.USD","LU1983299246.USD","LU0823416689.USD","LU0882574139.USD","LU2361044865.SGD","LU0708995401.HKD","LU0096364046.USD","LU1093756168.USD","SG9999014914.USD","LU1804176565.USD","IE00BK4W5M84.HKD","SG9999013999.USD","LU1023059063.AUD","SGXZ31699556.SGD","IE00BFTCPJ56.SGD","LU2237443978.SGD","LU0672654240.SGD","LU0122379950.USD","LU2357305700.SGD","LU1814569148.SGD","LU0943347566.SGD","LU1720051108.HKD","LU2112291526.USD","LU0198837287.USD","LU2552382058.USD","LU2471134523.USD","LU2750360997.AUD","LU0354030511.USD","BK4534","LLY","SG9999001176.SGD","IE00BJLML261.HKD","LU1551013425.SGD","LU0456855351.SGD","LU0203202063.USD","LU2063271972.USD"],"gpt_icon":1},{"id":"2527092429","title":"Pfizer Halts Obesity Pill Development Amid Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2527092429","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527092429?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:57","pubTimestamp":1744736220,"startTime":"0","endTime":"0","summary":"Pfizer PFE announced that it is discontinuing the development of danuglipron, its investigational oral GLP-1 receptor agonist , which is being developed to treat obesity.The decision follows a safety signal observed during two dose-optimization studies, in which one study participant experienced a case of potential drug-induced liver injury. Although the individual was asymptomatic and fully recovered after stopping the treatment, Pfizer stated that its decision was based on a comprehensive review of all clinical data generated to date, along with recent regulatory feedback.While the two dose-optimization studies had met key pharmacokinetic goals and identified a dose with the potential for competitive efficacy and tolerability, the safety concerns ultimately led Pfizer to stop further development of danuglipron.The obesity market has garnered much interest lately. Per a research conducted by Goldman Sachs, the obesity market in the United States is expected to reach $100 billion by 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-halts-obesity-pill-development-165700605.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1712237335.SGD","IE00BKVL7J92.USD","LU1366192091.USD","SG9999018857.SGD","LU1883839398.USD","LU2063271972.USD","LU2237443622.USD","LU1988902786.USD","IE00BLSP4239.USD","LU1551013425.SGD","LU1280957306.USD","LU2471134796.USD","LU0943347566.SGD","SG9999001176.SGD","LU0823416689.USD","LU0203202063.USD","LU2112291526.USD","LU2357305700.SGD","LU2106854487.HKD","SG9999017495.SGD","LU1894683264.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU0225771236.USD","BK4516","NVO","VKTX","LU0471298777.SGD","LU1989771016.USD","LU2361044949.HKD","IE0004445239.USD","LLY","LU1623119135.USD","SG9999002232.USD","SG9999014880.SGD","LU0094547139.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1868836914.USD","LU2361044865.SGD","PFE","LU0417517546.SGD","BK4592","LU0354030438.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0820561818.USD","LU2237438978.USD","SG9999014906.USD","LU1868836591.USD"],"gpt_icon":1},{"id":"2527290404","title":"VERV Stock Soars on Superior Efficacy in Phase I Cholesterol Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2527290404","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527290404?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:27","pubTimestamp":1744734420,"startTime":"0","endTime":"0","summary":"Shares of Verve Therapeutics VERV surged 26.4% on Monday and continue to soar today after the company announced positive initial datafrom an early-stage study of its investigational candidate, VERVE-102, which is being developed for reducing cholesterol levels. VERVE-102 is a novel,in vivo, investigational base editing medicine.The data readout includes 14 patients from the first three cohorts who received doses of VERVE-102 at 0.3 mg/kg, 0.45 mg/kg, or 0.6 mg/kg, respectively, with each participant having at least 28 days of follow-up as of the data cutoff date of March 13, 2025.More on VERV’s Phase I Cholesterol Drug Study Data. Verve Therapeutics reported that a single infusion of VERVE-102 resulted in dose-dependent reductions in blood PCSK9 protein levels and LDL-C in the Heart-2 study, with an average LDL-C decrease of 53% and a maximum reduction of 69% observed among four participants in the 0.6 mg/kg dose cohort.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/verv-stock-soars-superior-efficacy-162700742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1023059063.AUD","BK4588","SG9999015978.USD","LU2471134879.HKD","LU0079474960.USD","LU2324357040.USD","GB00BDT5M118.USD","LU1720051017.SGD","LU2468319806.SGD","SG9999015986.USD","LU1127390331.HKD","LU0320765059.SGD","LU1280957306.USD","LU2471134796.USD","LU2491050071.SGD","LU0943347566.SGD","VERV","LU2357305700.SGD","LU1712237335.SGD","BK4585","LU1623119135.USD","LU2089984988.USD","LU0122379950.USD","LU0640476718.USD","LU1093756325.SGD","IE00BK4W5L77.USD","LU0672654240.SGD","LU2023250504.SGD","IE00BK4W5M84.HKD","LU2063271972.USD","LU0094547139.USD","LU2360106947.USD","ADMA","LU0238689110.USD","LU0058720904.USD","SG9999001176.SGD","LU0106261372.USD","LU0820561909.HKD","LU2237443549.SGD","LU1035775433.USD","LU2491050154.USD","LU1093756168.USD","LU1551013425.SGD","BAYRY","LLY","LU1868836757.USD","IE0009355771.USD","SGXZ81514606.USD","LU0198837287.USD","LU1720051108.HKD"],"gpt_icon":1},{"id":"2527444107","title":"NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2527444107","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527444107?lang=en_us&edition=fundamental","pubTime":"2025-04-15 22:00","pubTimestamp":1744725600,"startTime":"0","endTime":"0","summary":"Obesity stocks like Novo Nordisk NVO, Eli Lilly LLY, Structure Therapeutics GPCR and Viking Therapeutics VKTX gained 2.1%, 3%, 10.6% and 19.2%, respectively, on Monday after pharma bigwig Pfizer PFE announced that it is discontinuing the development of its GLP-1R weight loss pill, danuglipron.After reviewing all clinical data and considering regulatory feedback, Pfizer concluded that halting the program was the best course of action. This decision reverted Pfizer’s developmental program for an obesity candidate back to the early clinical stages and has significantly delayed its hopes for marketing an obesity drug that would compete with Lilly’s Zepbound and Novo Nordisk’s Wegovy for market share.How PFE’s Obesity Study Setback Benefits VKTX, GPCR, LLY & NVO. Shares of Lilly, Novo Nordisk, Viking Therapeutics and Structure Therapeutics rose as Pfizer's decision to discontinue its obesity pill program removes a ke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvo-lly-gpcr-vktx-stocks-140000975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1232071149.USD","LU1712237335.SGD","LU1868837300.USD","LU1883839398.USD","LU2360106947.USD","LU0820561909.HKD","LU1868836757.USD","LLY","LU1894683348.USD","PFE","IE00BLSP4452.SGD","BK4599","BK4588","SG9999013999.USD","SG9999011175.SGD","VKTX","IE0002141913.USD","LU2552382058.USD","LU0058720904.USD","LU0868494617.USD","BK4532","LU0456855351.SGD","LU0289739699.SGD","LU1917777945.USD","LU1069344957.HKD","SGXZ99366536.SGD","LU1983299246.USD","LU2361044865.SGD","LU2237443465.HKD","LU0882574055.USD","IE00BZ1G4Q59.USD","NVO","LU1127390331.HKD","LU0106261372.USD","LU2471134952.CNY","SG9999014914.USD","LU1291159041.SGD","IE000M9KFDE8.USD","LU1093756325.SGD","SGXZ81514606.USD","IE00BJT1NW94.SGD","LU0672654240.SGD","BK4568","LU0096364046.USD","LU0203202063.USD","BK4581","LU0354030438.USD","LU0985481810.HKD","LU1551013425.SGD","GPCR"],"gpt_icon":1},{"id":"2527008415","title":"Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2527008415","media":"TipRanks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527008415?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:08","pubTimestamp":1744718921,"startTime":"0","endTime":"0","summary":"European drugmaker Novartis , best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest $23 billion in U.S.-based manufacturing to conduct research and development and produce all its major drugs stateside. Judging by Novartis’ stock performance in the days following the news, the market signaled its approval. Donald Trump is likely to be delighted, too.Discover outperforming stocks and invest smarter with Top Smart Score Stocks.Filter, analyze, and streamline your search for investment opportunities using  Tipranks' Stock Screener.Novartis’ latest move is a reactive and proactive response to an evolving supply chain that increasingly favors manufacturing in host countries. Novartis’ recent financial performance, which allows such investments, and its prescient adaptations make me bullish on its stock.As has been the case for the last few quarters, Novartis’ revenue growth was driven","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/novartis-nvs-unleashes-23bn-strategic-120841357.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-nvs-unleashes-23bn-strategic-120841357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVS","BK4578","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU0471298777.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LLY","BK4559","LU1057294990.SGD","LU2265009873.SGD","IE00B2B36J28.USD","LU0234572021.USD","LU1868836914.USD","LU0097036916.USD","LU2264538146.SGD","IE00BK4W5M84.HKD","LU2471134879.HKD","LU0354030511.USD","LU1032466523.USD","BK4550","LU1059921491.USD","LU1868837136.USD","LU1267930813.SGD","LU0203201768.USD","LU1551013342.USD","LU1623119135.USD","LU2237438978.USD","SGXZ51526630.SGD","LU2750360641.GBP","LU0094547139.USD","IE00BJLML261.HKD","LU1720051017.SGD","LU2491049909.HKD","LU0640476718.USD","LU0417517546.SGD","SG9999015986.USD","LU0456855351.SGD","IE00BLSP4239.USD","JNJ","LU0689472784.USD","LU1914381329.SGD","LU1720051108.HKD","LU1989771016.USD","LU2430703178.SGD","LU0792757196.USD","LU2360106947.USD","LU1506573853.SGD","LU0256863811.USD"],"gpt_icon":1},{"id":"2527146274","title":"Eli Lilly and Company (LLY): One of the High Growth Forever Dividend Stocks to Invest In","url":"https://stock-news.laohu8.com/highlight/detail?id=2527146274","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527146274?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:48","pubTimestamp":1744717684,"startTime":"0","endTime":"0","summary":"We recently published a list of the10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where Eli Lilly and Company  stands against other high growth forever dividend stocks.Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring AI-focused companies. Still, experienced investors recognize the long-term value of dividend-paying stocks, supported by their strong historical performance. Short-term trends don’t diminish their importance. In fact, dividends have historically played a major role in total returns, accounting for about 31% of the broader market’s monthly total return from 1926 through February 2025, according to S&P Dow Jones Indices.The report emphasized that the most promising opportunities in the dividend space lie with so-called “Compounders","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-company-lly-one-114804634.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2491049909.HKD","LU1868837300.USD","LU2552382132.HKD","IE0004445239.USD","LU0109391861.USD","BK4581","LU0820561818.USD","LU2360106947.USD","LU1366192091.USD","LU0203201768.USD","LU2324357040.USD","BK4533","LU1868837136.USD","SG9999015986.USD","LU0689472784.USD","BK4007","LU1093756168.USD","IE00BJJMRZ35.SGD","BK4516","LU2750360997.AUD","LU0882574055.USD","LU2063271972.USD","IE00BFTCPJ56.SGD","SG9999014906.USD","IE0009355771.USD","LU1551013425.SGD","LU1868836914.USD","IE0002141913.USD","LU0061475181.USD","BK4599","LU1064131342.USD","LU0058720904.USD","LU0708995401.HKD","LU2750360641.GBP","SG9999001176.USD","LLY","LU0417517546.SGD","SG9999017495.SGD","LU2468319806.SGD","LU1814569148.SGD","LU0289739699.SGD","LU1069344957.HKD","LU1551013342.USD","LU1720051017.SGD","LU2237443549.SGD","LU2237443978.SGD","LU1127390331.HKD","LU0820561909.HKD","LU0256863902.USD","SG9999018865.SGD"],"gpt_icon":1},{"id":"2527496764","title":"Skye Bioscience Demonstrates Over 30% Weight Loss With Nimacimab and Tirzepatide Combination in Preclinical Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527496764","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527496764?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU2552382215.SGD","BK4585","IE00B2B36J28.USD","IE00BJLML261.HKD","LU2237443978.SGD","LU0354030511.USD","LU0320765059.SGD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","LU2461242641.AUD","SG9999015952.SGD","LU0471298777.SGD","LU0122379950.USD","LU0198837287.USD","LU1548497426.USD","LU1623119135.USD","LU2361045086.USD","LU0820561909.HKD","LU0354030438.USD","SGXZ31699556.SGD","LU2237443622.USD","LU1267930730.SGD","SG9999015986.USD","LU0882574139.USD","LU0385154629.USD","LU1061106388.HKD","LU0289739699.SGD","LU1814569148.SGD","LU2089984988.USD","IE0002141913.USD","LU1868837136.USD","LU2112291526.USD","LU2750360997.AUD","LLY","IE00BK4W5M84.HKD","IE00BJJMRZ35.SGD","LU2237438978.USD","SG9999018865.SGD","LU0823416689.USD","LU0256863811.USD","IE00B1BXHZ80.USD","SKYE","LU0708995401.HKD","SG9999014898.SGD","LU0456855351.SGD","SG9999014906.USD","LU1551013425.SGD","BK4139","LU0058720904.USD"],"gpt_icon":0},{"id":"2527449966","title":"Skye Bioscience Inc - Nimacimab Phase 2a Top-Line Data Expected Late Q3/Early Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527449966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527449966?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0238689110.USD","LU1023059063.AUD","SG9999014906.USD","SG9999015952.SGD","LU2491050071.SGD","LU0466842654.USD","LU2552382058.USD","LU1061106388.HKD","LU1804176565.USD","LU0256863811.USD","LU1064131342.USD","LU0823416689.USD","LU0097036916.USD","SKYE","LU1551013342.USD","BK4533","LU2552382132.HKD","LU1069344957.HKD","LU1548497426.USD","LU2264538146.SGD","BK4588","BK4585","IE0002141913.USD","SG9999014898.SGD","IE00BJJMRZ35.SGD","LU2237443382.USD","IE00BJLML261.HKD","LU0689472784.USD","LU2361044949.HKD","LU1720051017.SGD","LU2471134796.USD","LU1232071149.USD","LU0094547139.USD","LU1267930730.SGD","LU2750360641.GBP","LU1814569148.SGD","LU1868837300.USD","LU0114720955.EUR","SGXZ57979304.SGD","LLY","LU1868836914.USD","SG9999018865.SGD","LU2360106947.USD","SG9999001176.SGD","LU2750360997.AUD","LU1093756325.SGD","IE00B1BXHZ80.USD","IE0004445239.USD","LU0456855351.SGD","LU2361045086.USD"],"gpt_icon":0},{"id":"2527249965","title":"Skye Bioscience Inc - Nimacimab Shows Additive Weight Loss Effect With Tirzepatide in Dio Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2527249965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527249965?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUA5SCWWV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","LU1551013342.USD","LU2361044949.HKD","SG9999018865.SGD","BK4585","LU0689472784.USD","LU1868837300.USD","LU0238689110.USD","IE0002141913.USD","LU1814569148.SGD","LU0466842654.USD","LU1868836914.USD","BK4588","LU2491050071.SGD","LU0823416689.USD","SG9999014906.USD","SG9999001176.SGD","SKYE","LLY","LU1804176565.USD","LU2237443382.USD","LU2552382058.USD","LU1064131342.USD","IE00B1BXHZ80.USD","LU2361045086.USD","LU0256863811.USD","SGXZ57979304.SGD","LU2552382132.HKD","IE00BJLML261.HKD","LU2471134796.USD","LU0114720955.EUR","IE0004445239.USD","LU2264538146.SGD","IE00BJJMRZ35.SGD","LU2750360997.AUD","SG9999015952.SGD","LU0094547139.USD","LU1720051017.SGD","LU1061106388.HKD","BK4533","LU1093756325.SGD","LU0097036916.USD","LU1548497426.USD","LU2360106947.USD","LU0456855351.SGD","LU2750360641.GBP","LU1069344957.HKD","SG9999014898.SGD","LU1232071149.USD","LU1267930730.SGD"],"gpt_icon":0},{"id":"2527250496","title":"Market Chatter: China's New Tariffs to Affect US-Made Drugs, Increase Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527250496","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527250496?lang=en_us&edition=fundamental","pubTime":"2025-04-15 18:54","pubTimestamp":1744714458,"startTime":"0","endTime":"0","summary":"Multiple US-manufactured medicines, including treatments for cancer and diabetes, are now subject to new Chinese tariffs that could increase drugmakers' costs, Reuters reported Tuesday, citing regulatory filings from China.According to records from China's National Medical Products Administration, pharmaceutical firms like AstraZeneca , Eli Lilly , Sanofi , and GSK  produce drugs in the US that are sold in China, the report said.Industry analysts warn that additional costs resulting from these tariffs may either raise prices or reduce the availability of specific drugs in China, as shifting production locations would be challenging in the short term, the report said.The US government is also investigating whether pharmaceutical imports pose a national security risk, which could result in increased duties on foreign drugs, the report said.AstraZeneca, Eli Lilly, Sanofi, and GSK did not immediately respond to MT Newswires' request for comment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","LU1720051017.SGD","LU0079474960.USD","LU2468319806.SGD","GSK.UK","LU0471298777.SGD","SG9999014906.USD","BK4532","SG9999018865.SGD","LU2063271972.USD","LLY","SG9999015986.USD","LU2265009873.SGD","SGXZ51526630.SGD","IE00BFXG1179.USD","SG9999017495.SGD","LU0198837287.USD","LU1551013342.USD","LU0456855351.SGD","LU0672654240.SGD","LU1035775433.USD","LU2237443978.SGD","LU1366192091.USD","GSK","LU0061475181.USD","LU0882574139.USD","LU0256863902.USD","SNY","LU2106854487.HKD","LU1267930730.SGD","AZN","LU0466842654.USD","IE00BJT1NW94.SGD","BK4568","LU2471134523.USD","LU2750360997.AUD","LU1069344957.HKD","LU0256863811.USD","LU0096364046.USD","LU2361044949.HKD","LU0689472784.USD","LU1868836591.USD","SG9999001176.SGD","LU1868836757.USD","LU2360106947.USD","LU0058720904.USD","LU2361044865.SGD","LU1988902786.USD","LU1057294990.SGD","LU1280957306.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":20,"pageCount":17,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LLY\",params:#limit:5,,,undefined,":[{"date":"2025-05-16","symbol":"LLY","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-06-10"},{"market":"US","date":"2025-05-01","symbol":"LLY","fiscalQuarterEnding":"2025/03","expectedEps":3.52,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":3.34},{"date":"2025-02-14","symbol":"LLY","amount":1.5,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-10","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-03-10"},{"market":"US","date":"2025-02-06","symbol":"LLY","fiscalQuarterEnding":"2024/12","expectedEps":5.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":5.32},{"date":"2024-11-15","symbol":"LLY","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"礼来","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-12-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LLY\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-09-10","value":0.5,"currency":"USD"},{"executeDate":"2015-11-10","recordDate":"2015-11-13","paymentDate":"2015-12-10","value":0.5,"currency":"USD"},{"executeDate":"2016-02-10","recordDate":"2016-02-12","paymentDate":"2016-03-10","value":0.51,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-06-10","value":0.51,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-09-09","value":0.51,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LLY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.5,"hold":0.1667,"sell":0.0333,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":30,"updateTime":1746158400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LLY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LLY","date":"2025-05-16","current":59.272183,"percent":0.601633,"low":21.223959,"twenty":30.230011,"median":51.599969,"eighty":86.502754,"high":139.115155,"avg":61.353834,"sd":32.588509,"marketCap":658300575521},"quantilePoints":[{"date":"2020-05-22","current":24.762628,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":137019049719},{"date":"2020-05-29","current":25.055861,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":138641596021},{"date":"2020-06-05","current":24.443184,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":135251471346},{"date":"2020-06-12","current":23.51434,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":130111897305},{"date":"2020-06-19","current":26.200944,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":144977684653},{"date":"2020-06-26","current":26.674376,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":147597326447},{"date":"2020-07-02","current":26.844746,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":148540034913},{"date":"2020-07-10","current":26.761199,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":148077745185},{"date":"2020-07-17","current":27.187125,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":150434516350},{"date":"2020-07-24","current":26.135417,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":144615104473},{"date":"2020-07-31","current":24.249022,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136233432207},{"date":"2020-08-07","current":24.674982,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":138626513989},{"date":"2020-08-14","current":24.216753,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136052138133},{"date":"2020-08-21","current":24.082834,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":135299767724},{"date":"2020-08-28","current":23.773045,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":133559344610},{"date":"2020-09-04","current":24.349058,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136795443838},{"date":"2020-09-11","current":23.894056,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":134239197389},{"date":"2020-09-18","current":24.875053,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":139750537251},{"date":"2020-09-25","current":24.244182,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":136206238096},{"date":"2020-10-02","current":23.429373,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":131628562718},{"date":"2020-10-09","current":25.312307,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":142207071959},{"date":"2020-10-16","current":23.5762,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":132453450756},{"date":"2020-10-23","current":22.972758,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129063251565},{"date":"2020-10-30","current":21.223959,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":118272635275},{"date":"2020-11-06","current":23.221738,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129405457298},{"date":"2020-11-13","current":23.163171,"twenty":15.251094,"median":32.585712,"eighty":38.329717,"marketCap":129079087923},{"date":"2020-11-20","current":23.669123,"twenty":15.251094,"median":32.518779,"eighty":38.329717,"marketCap":131898556693},{"date":"2020-11-27","current":23.98636,"twenty":15.251094,"median":32.403561,"eighty":38.329717,"marketCap":133666390809},{"date":"2020-12-04","current":24.150673,"twenty":15.251094,"median":32.241495,"eighty":38.329717,"marketCap":134582038223},{"date":"2020-12-11","current":26.036198,"twenty":15.251094,"median":31.923161,"eighty":38.329717,"marketCap":145089318943},{"date":"2020-12-18","current":27.884306,"twenty":15.251094,"median":31.731782,"eighty":38.329717,"marketCap":155388085897},{"date":"2020-12-24","current":27.113177,"twenty":15.251094,"median":30.933068,"eighty":38.329717,"marketCap":151090889122},{"date":"2020-12-31","current":27.467831,"twenty":15.251094,"median":30.534112,"eighty":38.329717,"marketCap":153067237006},{"date":"2021-01-08","current":27.072505,"twenty":15.251094,"median":30.250726,"eighty":38.329717,"marketCap":150864243723},{"date":"2021-01-15","current":31.035526,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":172948571450},{"date":"2021-01-22","current":33.536003,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":186882730611},{"date":"2021-01-29","current":30.440896,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":188541774936},{"date":"2021-02-05","current":29.533392,"twenty":15.251094,"median":30.179801,"eighty":38.329717,"marketCap":182920969028},{"date":"2021-02-12","current":30.341363,"twenty":15.251094,"median":30.18994,"eighty":38.329717,"marketCap":187925299449},{"date":"2021-02-19","current":29.468797,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":182520890237},{"date":"2021-02-26","current":30.051075,"twenty":15.251094,"median":30.223302,"eighty":38.329717,"marketCap":186127340238},{"date":"2021-03-05","current":30.348813,"twenty":15.245453,"median":30.2533,"eighty":38.329717,"marketCap":187971444395},{"date":"2021-03-12","current":30.51895,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":189025218199},{"date":"2021-03-19","current":27.046542,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":167518164982},{"date":"2021-03-26","current":27.196238,"twenty":15.251094,"median":30.2732,"eighty":38.329717,"marketCap":168445336984},{"date":"2021-04-01","current":27.185964,"twenty":15.251094,"median":30.2732,"eighty":38.329717,"marketCap":168381707533},{"date":"2021-04-09","current":27.075894,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":167699963413},{"date":"2021-04-16","current":27.774475,"twenty":15.245453,"median":30.281345,"eighty":38.329717,"marketCap":172026766090},{"date":"2021-04-23","current":27.696692,"twenty":15.245453,"median":30.248153,"eighty":38.329717,"marketCap":171545000246},{"date":"2021-04-30","current":27.270017,"twenty":15.245453,"median":30.181429,"eighty":38.329717,"marketCap":166142580765},{"date":"2021-05-07","current":29.157448,"twenty":15.245453,"median":30.118878,"eighty":38.329717,"marketCap":177641752657},{"date":"2021-05-14","current":29.275319,"twenty":15.245453,"median":30.051075,"eighty":38.329717,"marketCap":178359882759},{"date":"2021-05-21","current":29.822898,"twenty":15.245453,"median":29.916885,"eighty":38.329717,"marketCap":181696006146},{"date":"2021-05-28","current":29.802009,"twenty":15.245453,"median":29.887844,"eighty":38.329717,"marketCap":181568742584},{"date":"2021-06-04","current":30.142195,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":183641320600},{"date":"2021-06-11","current":33.435127,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":203703512194},{"date":"2021-06-18","current":32.608537,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":198667511223},{"date":"2021-06-25","current":34.349748,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":209275838178},{"date":"2021-07-02","current":34.907771,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":212675593346},{"date":"2021-07-09","current":35.061451,"twenty":15.245453,"median":29.856706,"eighty":38.329717,"marketCap":213611889555},{"date":"2021-07-16","current":34.683965,"twenty":15.245453,"median":29.856706,"eighty":38.265046,"marketCap":211312055177},{"date":"2021-07-23","current":36.42816,"twenty":15.245453,"median":29.856706,"eighty":38.222517,"marketCap":221938562640},{"date":"2021-07-30","current":36.331177,"twenty":15.245453,"median":29.856706,"eighty":38.176103,"marketCap":221347696101},{"date":"2021-08-06","current":39.341373,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":238829670451},{"date":"2021-08-13","current":39.456362,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":239527737739},{"date":"2021-08-20","current":40.456921,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":245601829722},{"date":"2021-08-27","current":38.790319,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":235484386956},{"date":"2021-09-03","current":38.757464,"twenty":15.245453,"median":29.856706,"eighty":38.153191,"marketCap":235284939160},{"date":"2021-09-10","current":35.766242,"twenty":15.245453,"median":29.856706,"eighty":38.08692,"marketCap":217126123873},{"date":"2021-09-17","current":34.362473,"twenty":15.245453,"median":29.856706,"eighty":37.984151,"marketCap":208604263479},{"date":"2021-09-24","current":34.598425,"twenty":15.245453,"median":29.856706,"eighty":37.827164,"marketCap":210036661290},{"date":"2021-10-01","current":34.286311,"twenty":15.245453,"median":29.856706,"eighty":37.693048,"marketCap":208141907223},{"date":"2021-10-08","current":34.935927,"twenty":15.245453,"median":29.856706,"eighty":37.668179,"marketCap":212085534108},{"date":"2021-10-15","current":35.524316,"twenty":15.245453,"median":29.856706,"eighty":37.622739,"marketCap":215657462826},{"date":"2021-10-22","current":36.400925,"twenty":15.245453,"median":29.856706,"eighty":37.545092,"marketCap":220979092668},{"date":"2021-10-29","current":38.671803,"twenty":15.245453,"median":29.856706,"eighty":37.545092,"marketCap":230963478040},{"date":"2021-11-05","current":40.226205,"twenty":15.245453,"median":29.856706,"eighty":37.622739,"marketCap":240246984145},{"date":"2021-11-12","current":39.414091,"twenty":15.245453,"median":29.856706,"eighty":37.668179,"marketCap":235396714842},{"date":"2021-11-19","current":39.573477,"twenty":15.245453,"median":29.856706,"eighty":37.693048,"marketCap":236348636855},{"date":"2021-11-26","current":39.523384,"twenty":15.245453,"median":29.856706,"eighty":37.732652,"marketCap":236049461365},{"date":"2021-12-03","current":37.278307,"twenty":15.245453,"median":29.894138,"eighty":37.820463,"marketCap":222640959872},{"date":"2021-12-10","current":37.059719,"twenty":15.245453,"median":29.916885,"eighty":37.820463,"marketCap":221335466827},{"date":"2021-12-17","current":40.593553,"twenty":15.245453,"median":29.916885,"eighty":37.863818,"marketCap":242440937736},{"date":"2021-12-23","current":41.45576,"twenty":15.245453,"median":29.916885,"eighty":37.970561,"marketCap":247590382528},{"date":"2021-12-31","current":41.929367,"twenty":15.245453,"median":29.916885,"eighty":38.066155,"marketCap":250418950794},{"date":"2022-01-07","current":39.391321,"twenty":15.251094,"median":29.928979,"eighty":38.149959,"marketCap":235260725983},{"date":"2022-01-14","current":37.056683,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":221317334979},{"date":"2022-01-21","current":36.895778,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":220356347042},{"date":"2022-01-28","current":37.205444,"twenty":15.251094,"median":29.928979,"eighty":38.205547,"marketCap":222205795524},{"date":"2022-02-04","current":39.222477,"twenty":15.251094,"median":29.928979,"eighty":38.218502,"marketCap":218928100254},{"date":"2022-02-11","current":38.165298,"twenty":15.251094,"median":29.928979,"eighty":38.233384,"marketCap":213027243793},{"date":"2022-02-18","current":38.905161,"twenty":15.251094,"median":29.928979,"eighty":38.33418,"marketCap":217156939662},{"date":"2022-02-25","current":40.552838,"twenty":15.251094,"median":29.928979,"eighty":38.439335,"marketCap":226353776557},{"date":"2022-03-04","current":42.496012,"twenty":15.251094,"median":29.928979,"eighty":38.500976,"marketCap":237199989011},{"date":"2022-03-11","current":43.050511,"twenty":15.251094,"median":29.928979,"eighty":38.673349,"marketCap":240295039653},{"date":"2022-03-18","current":46.500372,"twenty":15.251094,"median":29.928979,"eighty":38.758659,"marketCap":259551127322},{"date":"2022-03-25","current":46.723465,"twenty":15.251094,"median":29.928979,"eighty":38.841271,"marketCap":260796366356},{"date":"2022-04-01","current":47.313531,"twenty":15.251094,"median":29.928979,"eighty":38.993237,"marketCap":264089933366},{"date":"2022-04-08","current":50.388336,"twenty":15.251094,"median":29.928979,"eighty":39.135432,"marketCap":281252575702},{"date":"2022-04-14","current":48.799202,"twenty":15.251094,"median":29.928979,"eighty":39.231382,"marketCap":272382503454},{"date":"2022-04-22","current":45.059966,"twenty":15.251094,"median":29.928979,"eighty":39.342269,"marketCap":251511214429},{"date":"2022-04-29","current":42.902715,"twenty":15.251094,"median":29.928979,"eighty":39.394174,"marketCap":262963611970},{"date":"2022-05-06","current":43.603246,"twenty":15.251094,"median":29.928979,"eighty":39.442623,"marketCap":267257373067},{"date":"2022-05-13","current":42.829284,"twenty":15.251094,"median":29.928979,"eighty":39.525509,"marketCap":262513532191},{"date":"2022-05-20","current":43.889626,"twenty":15.251094,"median":29.928979,"eighty":39.567406,"marketCap":269012684207},{"date":"2022-05-27","current":47.50683,"twenty":15.251094,"median":29.928979,"eighty":39.684083,"marketCap":291183614145},{"date":"2022-06-03","current":44.300839,"twenty":15.251094,"median":29.928979,"eighty":39.75963,"marketCap":271533130972},{"date":"2022-06-10","current":43.6194,"twenty":15.251094,"median":29.928979,"eighty":39.831921,"marketCap":267356390618},{"date":"2022-06-17","current":42.722075,"twenty":15.251094,"median":29.928979,"eighty":39.99547,"marketCap":261856415713},{"date":"2022-06-24","current":47.821114,"twenty":15.245453,"median":29.916885,"eighty":40.119456,"marketCap":293109955601},{"date":"2022-07-01","current":47.68747,"twenty":15.245453,"median":29.916885,"eighty":40.231279,"marketCap":292290810402},{"date":"2022-07-08","current":48.533394,"twenty":15.245453,"median":29.916885,"eighty":40.282884,"marketCap":297475729462},{"date":"2022-07-15","current":48.699347,"twenty":15.245453,"median":29.916885,"eighty":40.411393,"marketCap":298492909764},{"date":"2022-07-22","current":48.280791,"twenty":15.245453,"median":29.916885,"eighty":40.485305,"marketCap":295927455021},{"date":"2022-07-29","current":48.418841,"twenty":15.245453,"median":29.916885,"eighty":40.547563,"marketCap":296773605006},{"date":"2022-08-05","current":50.303373,"twenty":15.245453,"median":29.916885,"eighty":40.622706,"marketCap":286306675858},{"date":"2022-08-12","current":51.43191,"twenty":15.245453,"median":29.916885,"eighty":40.962997,"marketCap":292729857621},{"date":"2022-08-19","current":53.884308,"twenty":15.245453,"median":29.916885,"eighty":41.240732,"marketCap":306687925683},{"date":"2022-08-26","current":52.680646,"twenty":15.245453,"median":29.916885,"eighty":41.859057,"marketCap":299837165252},{"date":"2022-09-02","current":50.305042,"twenty":15.245453,"median":29.916885,"eighty":42.05955,"marketCap":286316177606},{"date":"2022-09-09","current":53.037905,"twenty":15.245453,"median":29.916885,"eighty":42.276859,"marketCap":301870539360},{"date":"2022-09-16","current":51.567134,"twenty":15.245453,"median":29.916885,"eighty":42.479321,"marketCap":293499499223},{"date":"2022-09-23","current":51.996178,"twenty":15.245453,"median":29.916885,"eighty":42.744398,"marketCap":295941448502},{"date":"2022-09-30","current":53.981135,"twenty":15.245453,"median":29.916885,"eighty":42.964876,"marketCap":307239027076},{"date":"2022-10-07","current":54.533717,"twenty":15.245453,"median":29.916885,"eighty":43.406066,"marketCap":310384105721},{"date":"2022-10-14","current":55.323359,"twenty":15.245453,"median":29.916885,"eighty":43.814059,"marketCap":314878432605},{"date":"2022-10-21","current":56.889288,"twenty":15.245453,"median":29.916885,"eighty":44.425377,"marketCap":323791072389},{"date":"2022-10-28","current":60.082915,"twenty":15.245453,"median":29.916885,"eighty":44.787382,"marketCap":341967916638},{"date":"2022-11-04","current":56.289048,"twenty":15.245453,"median":29.916885,"eighty":45.700559,"marketCap":339603083239},{"date":"2022-11-11","current":55.484266,"twenty":15.245453,"median":29.916885,"eighty":46.033513,"marketCap":334747674170},{"date":"2022-11-18","current":56.959962,"twenty":15.245453,"median":29.916885,"eighty":46.096136,"marketCap":343650841093},{"date":"2022-11-25","current":57.523781,"twenty":15.245453,"median":29.916885,"eighty":46.503605,"marketCap":347052477975},{"date":"2022-12-02","current":59.021526,"twenty":15.245453,"median":29.916885,"eighty":46.820786,"marketCap":356088669804},{"date":"2022-12-09","current":56.852867,"twenty":15.245453,"median":29.916885,"eighty":47.19243,"marketCap":343004720121},{"date":"2022-12-16","current":56.676477,"twenty":15.245453,"median":29.916885,"eighty":47.35518,"marketCap":341940520873},{"date":"2022-12-23","current":57.941134,"twenty":15.245453,"median":29.916885,"eighty":47.609927,"marketCap":349570449410},{"date":"2022-12-30","current":57.616701,"twenty":15.245453,"median":29.916885,"eighty":47.946828,"marketCap":347613082936},{"date":"2023-01-06","current":57.159976,"twenty":15.245453,"median":29.916885,"eighty":48.055506,"marketCap":344857567026},{"date":"2023-01-13","current":56.952087,"twenty":15.245453,"median":29.916885,"eighty":48.352753,"marketCap":343603332198},{"date":"2023-01-20","current":54.503094,"twenty":15.245453,"median":29.916885,"eighty":48.597719,"marketCap":328828065853},{"date":"2023-01-27","current":53.877852,"twenty":15.245453,"median":29.916885,"eighty":48.85158,"marketCap":325055859590},{"date":"2023-02-03","current":51.592737,"twenty":15.325382,"median":29.992991,"eighty":49.895591,"marketCap":322186322332},{"date":"2023-02-10","current":52.511753,"twenty":15.471726,"median":30.118878,"eighty":50.310096,"marketCap":327925396848},{"date":"2023-02-17","current":49.967721,"twenty":15.626479,"median":30.243653,"eighty":50.433148,"marketCap":312038422360},{"date":"2023-02-24","current":46.452439,"twenty":15.778144,"median":30.341363,"eighty":50.433148,"marketCap":290086191606},{"date":"2023-03-03","current":45.988839,"twenty":15.854595,"median":30.51895,"eighty":50.433148,"marketCap":287191101832},{"date":"2023-03-10","current":45.496354,"twenty":15.907334,"median":32.742097,"eighty":50.433148,"marketCap":284115632632},{"date":"2023-03-17","current":47.541394,"twenty":15.945272,"median":33.093107,"eighty":50.433148,"marketCap":296886495936},{"date":"2023-03-24","current":48.545139,"twenty":15.990139,"median":33.435127,"eighty":50.433148,"marketCap":303154680962},{"date":"2023-03-31","current":49.597987,"twenty":16.097458,"median":33.751835,"eighty":50.410742,"marketCap":309729511010},{"date":"2023-04-06","current":52.316041,"twenty":16.2755,"median":34.072503,"eighty":50.694658,"marketCap":326703214922},{"date":"2023-04-13","current":53.299567,"twenty":16.395447,"median":34.265808,"eighty":51.019152,"marketCap":332845134350},{"date":"2023-04-21","current":54.131447,"twenty":16.469273,"median":34.485523,"eighty":51.319724,"marketCap":338040061796},{"date":"2023-04-28","current":61.907495,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":352055543134},{"date":"2023-05-05","current":71.517637,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":406706495414},{"date":"2023-05-12","current":72.704478,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":413455825968},{"date":"2023-05-19","current":73.095084,"twenty":16.478563,"median":34.486423,"eighty":51.368358,"marketCap":415677124631},{"date":"2023-05-26","current":71.329011,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":405633817000},{"date":"2023-06-02","current":72.861388,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":414348142525},{"date":"2023-06-09","current":74.392097,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":423052975320},{"date":"2023-06-16","current":75.772572,"twenty":16.477036,"median":34.485973,"eighty":51.335083,"marketCap":430903462476},{"date":"2023-06-23","current":76.398543,"twenty":16.475095,"median":34.485523,"eighty":51.273648,"marketCap":434463235975},{"date":"2023-06-30","current":77.535307,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":440927784649},{"date":"2023-07-07","current":77.321642,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":439712715294},{"date":"2023-07-14","current":72.562591,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":412648943975},{"date":"2023-07-21","current":77.423467,"twenty":16.473154,"median":34.443411,"eighty":51.236252,"marketCap":440291771784},{"date":"2023-07-28","current":75.949513,"twenty":16.561055,"median":34.520298,"eighty":51.486,"marketCap":431909691785},{"date":"2023-08-04","current":74.976337,"twenty":16.648676,"median":34.604947,"eighty":51.685351,"marketCap":426375430586},{"date":"2023-08-11","current":72.15676,"twenty":16.778484,"median":34.761377,"eighty":51.913041,"marketCap":468838545491},{"date":"2023-08-18","current":74.415551,"twenty":16.829645,"median":34.900087,"eighty":52.353704,"marketCap":483515042715},{"date":"2023-08-25","current":75.846673,"twenty":16.873693,"median":35.027681,"eighty":52.642583,"marketCap":492813754804},{"date":"2023-09-01","current":76.704792,"twenty":16.943276,"median":35.199465,"eighty":52.935996,"marketCap":498389384876},{"date":"2023-09-08","current":79.338664,"twenty":16.995723,"median":35.327937,"eighty":53.305793,"marketCap":515502972018},{"date":"2023-09-15","current":81.882573,"twenty":17.014221,"median":35.518939,"eighty":53.718848,"marketCap":532032017298},{"date":"2023-09-22","current":76.141478,"twenty":17.045869,"median":35.803576,"eighty":53.94207,"marketCap":494729253522},{"date":"2023-09-29","current":75.35533,"twenty":17.081428,"median":36.024425,"eighty":54.124515,"marketCap":489621256939},{"date":"2023-10-06","current":74.944263,"twenty":17.109303,"median":36.337145,"eighty":54.515343,"marketCap":486950350276},{"date":"2023-10-13","current":84.497069,"twenty":17.184663,"median":36.461597,"eighty":54.950742,"marketCap":549019703116},{"date":"2023-10-20","current":81.769735,"twenty":17.217338,"median":36.786995,"eighty":55.102822,"marketCap":531298853537},{"date":"2023-10-27","current":78.627939,"twenty":17.419573,"median":36.895778,"eighty":55.323359,"marketCap":510885035027},{"date":"2023-11-03","current":104.612169,"twenty":21.308556,"median":37.087043,"eighty":55.484266,"marketCap":521847345496},{"date":"2023-11-10","current":106.60299,"twenty":21.362242,"median":37.197854,"eighty":55.528364,"marketCap":531778355382},{"date":"2023-11-17","current":106.139671,"twenty":21.351505,"median":37.142449,"eighty":55.493086,"marketCap":529467135783},{"date":"2023-11-24","current":108.366125,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":540573580160},{"date":"2023-12-01","current":106.552512,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":531526549356},{"date":"2023-12-08","current":106.053137,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":529035468309},{"date":"2023-12-15","current":103.421053,"twenty":21.340768,"median":37.087043,"eighty":55.45884,"marketCap":515905582649},{"date":"2023-12-22","current":103.119986,"twenty":21.33003,"median":37.073381,"eighty":55.440571,"marketCap":514403739564},{"date":"2023-12-29","current":104.715462,"twenty":21.319293,"median":37.059719,"eighty":55.428569,"marketCap":522362608611},{"date":"2024-01-05","current":110.781873,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":552624297136},{"date":"2024-01-12","current":114.607409,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":571707596705},{"date":"2024-01-19","current":112.377349,"twenty":21.291637,"median":37.056683,"eighty":55.369554,"marketCap":560583166183},{"date":"2024-01-26","current":113.147143,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":564423208085},{"date":"2024-02-02","current":119.06212,"twenty":21.308556,"median":37.058201,"eighty":55.388467,"marketCap":593929478531},{"date":"2024-02-09","current":126.250353,"twenty":21.308556,"median":37.073381,"eighty":55.484266,"marketCap":661602348116},{"date":"2024-02-16","current":130.042943,"twenty":21.308556,"median":37.142449,"eighty":55.583486,"marketCap":681477038053},{"date":"2024-02-23","current":132.204139,"twenty":21.308556,"median":37.142449,"eighty":55.903194,"marketCap":692802568837},{"date":"2024-03-01","current":129.462626,"twenty":21.319293,"median":37.197854,"eighty":56.34606,"marketCap":678435944183},{"date":"2024-03-08","current":134.011201,"twenty":21.319293,"median":37.197854,"eighty":56.669232,"marketCap":702272298872},{"date":"2024-03-15","current":130.673632,"twenty":21.319293,"median":37.197854,"eighty":56.849402,"marketCap":684782103569},{"date":"2024-03-22","current":132.310639,"twenty":21.319293,"median":37.197854,"eighty":56.961222,"marketCap":693360670797},{"date":"2024-03-28","current":133.760431,"twenty":21.319293,"median":37.197854,"eighty":57.206593,"marketCap":700958163698},{"date":"2024-04-05","current":132.024354,"twenty":21.308556,"median":37.142449,"eighty":57.495433,"marketCap":691860426088},{"date":"2024-04-12","current":130.565018,"twenty":21.308556,"median":37.142449,"eighty":57.616701,"marketCap":684212921899},{"date":"2024-04-19","current":128.220455,"twenty":21.308556,"median":37.263886,"eighty":57.958458,"marketCap":671926472295},{"date":"2024-04-26","current":124.597039,"twenty":21.319293,"median":37.62744,"eighty":58.29108,"marketCap":652938322907},{"date":"2024-05-03","current":110.879942,"twenty":21.47727,"median":37.84451,"eighty":58.946995,"marketCap":680625435331},{"date":"2024-05-10","current":113.17408,"twenty":22.864826,"median":37.995307,"eighty":61.6157,"marketCap":694707775568},{"date":"2024-05-17","current":113.111006,"twenty":23.063427,"median":38.439376,"eighty":70.063714,"marketCap":694320601252},{"date":"2024-05-24","current":118.586722,"twenty":23.228414,"median":38.682429,"eighty":71.395781,"marketCap":727932734311},{"date":"2024-05-31","current":119.556304,"twenty":23.350464,"median":38.790319,"eighty":71.918926,"marketCap":733884413913},{"date":"2024-06-07","current":122.81709,"twenty":23.554918,"median":38.989059,"eighty":72.528204,"marketCap":753900425643},{"date":"2024-06-14","current":129.570424,"twenty":23.602801,"median":39.184569,"eighty":72.766241,"marketCap":795355089615},{"date":"2024-06-21","current":129.960603,"twenty":23.67921,"median":39.296727,"eighty":72.915472,"marketCap":797750167942},{"date":"2024-06-28","current":133.341671,"twenty":23.787075,"median":39.374944,"eighty":73.112857,"marketCap":818504512089},{"date":"2024-07-05","current":131.736947,"twenty":23.894379,"median":39.421898,"eighty":73.780474,"marketCap":808654077166},{"date":"2024-07-12","current":137.023441,"twenty":23.991133,"median":39.480285,"eighty":74.382117,"marketCap":841104687278},{"date":"2024-07-15","current":139.115155,"twenty":24.015067,"median":39.50365,"eighty":74.400109,"marketCap":853944468082},{"date":"2024-08-02","current":122.105672,"twenty":24.163214,"median":39.66911,"eighty":74.478664,"marketCap":749533459521},{"date":"2024-08-09","current":103.666328,"twenty":24.216107,"median":39.819389,"eighty":74.957093,"marketCap":761138914401},{"date":"2024-08-16","current":114.246227,"twenty":24.283953,"median":40.100005,"eighty":75.390022,"marketCap":838818646269},{"date":"2024-08-23","current":117.016598,"twenty":24.408112,"median":40.312064,"eighty":75.622149,"marketCap":859159264594},{"date":"2024-08-30","current":115.303358,"twenty":24.49169,"median":40.4539,"eighty":75.712813,"marketCap":846580316475},{"date":"2024-09-06","current":111.936971,"twenty":24.641744,"median":40.593553,"eighty":75.853756,"marketCap":821863628869},{"date":"2024-09-13","current":114.668098,"twenty":24.686059,"median":41.45576,"eighty":76.127084,"marketCap":841916110945},{"date":"2024-09-20","current":112.21781,"twenty":24.765221,"median":41.961244,"eighty":76.384522,"marketCap":823925603901},{"date":"2024-09-27","current":111.516326,"twenty":24.962812,"median":42.261802,"eighty":76.589989,"marketCap":818775168450},{"date":"2024-10-04","current":108.601243,"twenty":25.074864,"median":42.357434,"eighty":76.666318,"marketCap":797372047707},{"date":"2024-10-11","current":111.684339,"twenty":25.269358,"median":42.70592,"eighty":77.022845,"marketCap":820008751766},{"date":"2024-10-18","current":112.472895,"twenty":25.681877,"median":42.902715,"eighty":77.362372,"marketCap":825798489519},{"date":"2024-10-25","current":109.308859,"twenty":25.853979,"median":43.309522,"eighty":77.934384,"marketCap":802567504446},{"date":"2024-10-31","current":90.988842,"twenty":25.962098,"median":43.6194,"eighty":78.93258,"marketCap":761567509150},{"date":"2024-11-08","current":85.683138,"twenty":26.195803,"median":44.282481,"eighty":79.978102,"marketCap":717159300180},{"date":"2024-11-15","current":84.582455,"twenty":26.330032,"median":44.543895,"eighty":82.210596,"marketCap":707946685954},{"date":"2024-11-22","current":80.676233,"twenty":26.519078,"median":44.994283,"eighty":82.210596,"marketCap":675251998436},{"date":"2024-11-29","current":85.563582,"twenty":26.676342,"median":45.255888,"eighty":82.923666,"marketCap":716158626195},{"date":"2024-12-06","current":88.820022,"twenty":26.753791,"median":45.725105,"eighty":84.267868,"marketCap":743414704167},{"date":"2024-12-13","current":84.165045,"twenty":26.822269,"median":45.965739,"eighty":85.17408,"marketCap":704453009623},{"date":"2024-12-20","current":81.49599,"twenty":26.880469,"median":46.071101,"eighty":85.17408,"marketCap":682113290611},{"date":"2024-12-27","current":85.433411,"twenty":26.945486,"median":46.130976,"eighty":85.563582,"marketCap":715069103422},{"date":"2025-01-03","current":83.704603,"twenty":27.014133,"median":46.504413,"eighty":85.563582,"marketCap":700599160475},{"date":"2025-01-10","current":84.688958,"twenty":27.076516,"median":46.818846,"eighty":85.563582,"marketCap":708838113677},{"date":"2025-01-17","current":81.502445,"twenty":27.115129,"median":47.111453,"eighty":85.598008,"marketCap":682167316534},{"date":"2025-01-24","current":82.470663,"twenty":27.184274,"median":47.284431,"eighty":85.598008,"marketCap":690271204930},{"date":"2025-01-31","current":88.562907,"twenty":27.226987,"median":47.357031,"eighty":85.973461,"marketCap":741262671582},{"date":"2025-02-07","current":74.004631,"twenty":27.291918,"median":47.541394,"eighty":86.491996,"marketCap":783709038136},{"date":"2025-02-14","current":74.13132,"twenty":27.393617,"median":47.68747,"eighty":86.491996,"marketCap":785050681881},{"date":"2025-02-21","current":74.051954,"twenty":27.469575,"median":47.906294,"eighty":86.491996,"marketCap":784210189526},{"date":"2025-02-28","current":76.769363,"twenty":27.750068,"median":48.050219,"eighty":86.491996,"marketCap":812987556294},{"date":"2025-03-07","current":77.413942,"twenty":27.999171,"median":48.308222,"eighty":86.502754,"marketCap":819813648287},{"date":"2025-03-14","current":67.990366,"twenty":28.826215,"median":48.520491,"eighty":86.502754,"marketCap":720017979698},{"date":"2025-03-21","current":71.460916,"twenty":29.057481,"median":48.692738,"eighty":86.502754,"marketCap":756771096057},{"date":"2025-03-28","current":69.674291,"twenty":29.173861,"median":49.06693,"eighty":86.502754,"marketCap":737850745702},{"date":"2025-04-04","current":66.911639,"twenty":29.468797,"median":49.605593,"eighty":86.502754,"marketCap":708594259162},{"date":"2025-04-11","current":61.130251,"twenty":29.547726,"median":49.947,"eighty":86.491996,"marketCap":647369358847},{"date":"2025-04-17","current":62.316546,"twenty":29.70028,"median":50.303373,"eighty":86.491996,"marketCap":659932227069},{"date":"2025-04-25","current":72.901625,"twenty":29.802009,"median":50.543771,"eighty":86.502754,"marketCap":772028212789},{"date":"2025-05-02","current":64.187485,"twenty":29.988514,"median":51.011538,"eighty":86.502754,"marketCap":712891880459},{"date":"2025-05-09","current":60.740065,"twenty":30.117414,"median":51.296686,"eighty":86.502754,"marketCap":674603454943},{"date":"2025-05-16","current":59.272183,"twenty":30.230011,"median":51.599969,"eighty":86.502754,"marketCap":658300575521}],"updateTime":1747538652772}}}